Nektar Therapeutics (LON:0UNL)

Nektar Therapeutics Revenue

Nektar Therapeutics had revenue of $11.79M USD in the quarter ending September 30, 2025, a decrease of -51.13%. This brings the company's revenue in the last twelve months to $62.60M, down -32.79% year-over-year. In the year 2024, Nektar Therapeutics had annual revenue of $98.43M with 9.22% growth.

• Revenue (ttm): $62.60M
• Revenue Growth: -32.79%
• P/S Ratio: 22.77
• Revenue / Employee: $1.03M
• Employees: 61
• Market Cap: 1.06B GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	98.43M	8.31M	9.22%
Dec 31, 2023	90.12M	-1.93M	-2.10%
Dec 31, 2022	92.06M	-9.85M	-9.67%
Dec 31, 2021	101.91M	-51.01M	-33.36%
Dec 31, 2020	152.92M	38.30M	33.41%
Dec 31, 2019	114.62M	-1.08B	-90.40%
Dec 31, 2018	1.19B	885.61M	287.81%
Dec 31, 2017	307.71M	142.28M	86.00%
Dec 31, 2016	165.44M	-65.35M	-28.32%
Dec 31, 2015	230.78M	30.08M	14.99%
Dec 31, 2014	200.71M	51.79M	34.77%
Dec 31, 2013	148.92M	67.73M	83.42%
Dec 31, 2012	81.19M	9.71M	13.59%
Dec 31, 2011	71.48M	-87.56M	-55.06%
Dec 31, 2010	159.04M	87.11M	121.10%
Dec 31, 2009	71.93M	-18.25M	-20.24%
Dec 31, 2008	90.19M	-182.84M	-66.97%
Dec 31, 2007	273.03M	55.31M	25.40%
Dec 31, 2006	217.72M	91.44M	72.41%
Dec 31, 2005	126.28M	-	-